title: Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
abstract: OBJECTIVE
  The tripeptide tyroservatide (tyrosyl-seryl-valine, p-Tyr-Ser-Val-NH(2), YSV) has been shown to have anti-tumor effects on experimental hepatocarcinoma. The study was conducted to evaluate the therapeutic effects of YSV on tumor growth, invasion and metastasis of lung cancers.
  
  
  METHODS
  Anti-tumor and anti-metastatic effects of YSV were evaluated in three experimental systems. In C57BL/6 mice, a spontaneous metastasis model of Lewis lung cancer was used to study the anti-tumor and anti-metastasis effects of YSV. A549 human lung carcinoma was used to create an orthotopic model in nude mice to investigate the anti-metastasis effect of YSV. Finally, an in vitro model using the B16F10 melanoma cell line was selected to observe the effect of YSV on adhesion and invasion, and to use immunocytochemistry to assay the expression of ICAM-1.
  
  
  RESULTS
  YSV inhibited subcutaneous tumor growth of Lewis lung carcinoma (p < 0.05) and markedly decreased lung metastases in the spontaneous metastasis model of Lewis lung cancer and the orthotopic model of A549 human lung carcinoma. In vitro, YSV reduced adhesion and invasion as well as the expression of ICAM-1 in tumor cells.
  
  
  CONCLUSIONS
  YSV was able to inhibit tumor growth and metastasis in lung cancer.
authors.affiliation: Department of Immunology, Tianjin Medical University, Tianjin, China.
authors.forename: Minna
authors.initials: M
authors.lastname: Zheng
authors.forename: Rong
authors.initials: R
authors.lastname: Lu
authors.forename: Xuchun
authors.initials: X
authors.lastname: Che
authors.forename: Jinping
authors.initials: J
authors.lastname: Li
authors.forename: Chunlei
authors.initials: C
authors.lastname: Zhou
authors.forename: Li
authors.initials: L
authors.lastname: Wang
authors.forename: Qiong
authors.initials: Q
authors.lastname: Xu
authors.forename: Huiling
authors.initials: H
authors.lastname: Cao
authors.forename: Qiuli
authors.initials: Q
authors.lastname: Li
authors.forename: Zhi
authors.initials: Z
authors.lastname: Yao
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D014408:Biomarkers, Tumor / Q000032:analysis; D002277:Carcinoma / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology* / Q000556:secondary; D018827:Carcinoma, Lewis Lung / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology*; D002448:Cell Adhesion / Q000187:drug effects; D004195:Disease Models, Animal; D006801:Humans; D007150:Immunohistochemistry; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D008175:Lung Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology* / Q000556:secondary; D008546:Melanoma, Experimental / Q000188:drug therapy / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D008819:Mice, Nude; D009361:Neoplasm Invasiveness / Q000517:prevention & control; D009842:Oligopeptides / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D009842:Oligopeptides; C510683:tripeptide tyroservatide; D018799:Intercellular Adhesion Molecule-1